Pfizer reported better-than-expected quarterly profits on Tuesday behind cost cuts and growth in some non-Covid-related products including the blood clot drug Eliquis.

Boston Scientific stock dipped Wednesday, but the medtech company beat Wall Street's fourth-quarter forecasts.

Since the beginning of 2024, PFE stock has underperformed the S&P 500 index, delivering -3% returns compared to the index’s ...

Sen. Bill Cassidy, a Republican from Louisiana, said he was swayed after nominee Robert F. Kennedy Jr. agreed to significant vaccine concessions, Stat and The Hill reported. Also in the news, Pfizer's ...

TD Cowen analyst Steve Scala maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The company’s ...

Bose, 54, promised a junior colleague more money for a 'couple of hours' work than he would make in a month if she went along ...

Pfizer CEO Albert Bourla has revealed that he recently dined with health secretary nominee and vaccine skeptic Robert F. Kennedy Jr. – and vaccine talk was apparently not on the menu. At such a ...

Even well-known drugs can cause entirely unpredictable effects on metabolism, Swiss researchers have shown. Rapidly mapping the diverse effects of molecules on thousands of different metabolites could ...

Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's "radical" changes.

Pfizer Inc (PFE) reports robust financial performance with significant revenue growth and strategic progress in oncology and ...

Good day, everyone, and welcome to Pfizer's fourth-quarter 2024 earnings conference call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMartino, Chief ...

Healthcare was the only sector in the red by afternoon trading on the ASX, following a similar retreat on Wall Street ...